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N E U RO - O N CO LO G Y
Abstracts
EG-12. NOVEL CHROMATIN REGULATORY ACTIVITY OF
ESCO2 IN CANCER AND NEURAL DEVELOPMENT
Nathan Rockwell2, Alec Weech3, Jocelyn Terry3, Timothy E. VanMeter1,3,
James Lister1, and Asadullah Khan1; 1VCU School of Medicine, Richmond,
VA,USA; 2UniversityofRichmond,Richmond,VA,USA; 3College ofWilliam
and Mary, Williamsburg, VA, USA
ESCO2 has a well characterized role in the stabilization of the cohesin ring
through its acetyltransferase activity. Quantitative PCR studies comparing
RNA from tissue collected from ependymoma biopsies and tissue from non-
tumor brain, showan increased level of ESCO2 transcription in ependymoma.
High levels of ESCO2 protein expression in ependymoma tissue samples were
confirmed via immunostaining and confocal microscopy. ESCO2 expression
ordinarily peaks during mitosis in order to stabilize the cohesin ring, and is
reported to increase the rate of replication.However, someESCO2 expressing
cells are notmitotic in these tumors. Because of the detrimental effects of dele-
tionofESCO2onneuraldevelopmentand itshighexpression in ependymoma,
a type of tumor that exhibitsmany characteristics of primitive neural cells, the
current study sought to investigate the broader role of ESCO2 in primitive
neural cells. Studies carried out in Zebrafish were performed to explore the
possibility of an additional role for ESCO2 as a regulator of neural develop-
ment. QPCR on Zebrafish embryos at developmental timepoints indicated
that ESCO2 expression was highest 48 hours post-fertilization, and then
declined thereafter. Confocal microscopy on transgenic NeuroD-EGFP
embryos at 24-96 hpf confirmed that the proportion of ESCO2 positive
brain cells decreases by 96 hpf, that non-mitotic ESCO2 expressing cells
decline, and that 48 hpf appear to display a unique pattern of ESCO2 staining
associated with the 4th ventricle. Using FACS and subsequent chromatin im-
munoprecipitation studies, Esco2- bound chromatin was isolated from NT2
neural progenitor cells andNeuroD-EGFP+ transgenic zebrafish, and utilized
to identify novel sites of Esco2 regulation. The data obtained suggests an addi-
tional layer of neural regulatory activity that may be unrelated to the reported
SMC3acetyltransferase activityof ESCO2, and that could playa role in neural
pathologies such as cancer. Esco2 may be a novel therapeutic target for
ependymoma.
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